Total Clarity Wealth Management, Inc. Crispr Therapeutics Ag Transaction History

Total Clarity Wealth Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	BUY	$43.23 - $73.83 $3,199 - $5,463	74 New	74 $4,000
Q1 2022 Apr 29, 2022	SELL	$53.19 - $79.24 $19,148 - $28,526	-360 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$70.09 - $111.29 $10,513 - $16,693	-150 Reduced 29.41%	360 $27,000
Q3 2021 Oct 21, 2021	BUY	$110.2 - $156.64 $56,202 - $79,886	510 New	510 $57,000
Q2 2021 Jul 26, 2021	SELL	$100.84 - $161.89 $26,218 - $42,091	-260 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$110.72 - $210.04 $28,787 - $54,610	260 New	260 $32,000
Q1 2020 Apr 24, 2020	SELL	$33.68 - $62.53 $3,368 - $6,253	-100 Closed	0 $0
Q4 2019 Feb 27, 2020	BUY	$36.68 - $73.13 $3,668 - $7,313	100 New	100 $6,000

488

59M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Total Clarity Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Total Clarity Wealth Management, Inc. with notifications on news.